DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SILODOSIN

« Back to Dashboard

Clinical Trials for Silodosin

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00224107	A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo	Completed	Watson Pharmaceuticals	Phase 3	2005-05-01	A new drug for benign prostatic hyperplasia is compared to placebo for to determine if it is safe and effective. The study lasts approximately 20 weeks.
NCT00224120	A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo	Completed	Watson Pharmaceuticals	Phase 3	2005-05-01	A new drug for benign prostatic hyperplasia is compared to placebo for to determine if it is safe and effective. The study lasts approximately 20 weeks.
NCT00224133	The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months	Completed	Watson Pharmaceuticals	Phase 3	2005-09-01	A new drug for benign prostatic hyperplasia is used for 9 months to determine its long-term safety.

Clinical Trial Conditions for Silodosin

Condition Name

Condition Name for Silodosin
Intervention	Trials
Benign Prostatic Hyperplasia	7
Benign Prostatic Hyperplasia (BPH)	2
Nocturia	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Silodosin
Intervention	Trials
Prostatic Hyperplasia	11
Hyperplasia	10
Nephrolithiasis	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Silodosin

Trials by Country

Trials by Country for Silodosin
Location	Trials
United States	130
Korea, Republic of	9
Japan	2
France	1
United Kingdom	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Silodosin
Location	Trials
Pennsylvania	7
California	6
New York	6
Washington	5
South Carolina	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Silodosin

Clinical Trial Phase

Clinical Trial Phase for Silodosin
Clinical Trial Phase	Trials
Phase 4	8
Phase 3	6
Phase 2	6

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Silodosin
Clinical Trial Phase	Trials
Completed	15
Terminated	2
Unknown status	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Silodosin

Sponsor Name

Sponsor Name for Silodosin
Sponsor	Trials
Watson Pharmaceuticals	6
JW Pharmaceutical	5
Kissei Pharmaceutical Co., Ltd.	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Silodosin
Sponsor	Trials
Other	16
Industry	15

Export unavailable in trial.
Subscribe for complete access.